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Execution of fundamental cellular functions demands regulated protein folding homeosta-
sis. Endoplasmic reticulum (ER) is an active organelle existing to implement this function
by folding and modifying secretory and membrane proteins. Loss of protein folding home-
ostasis is central to various diseases and budding evidences suggest ER stress as being
a major contributor in the development or pathology of a diseased state besides other
cellular stresses. The trigger for diseases may be diverse but, inflammation and/or ER
stress may be basic mechanisms increasing the severity or complicating the condition
of the disease. Chronic ER stress and activation of the unfolded-protein response (UPR)
through endogenous or exogenous insults may result in impaired calcium and redox home-
ostasis, oxidative stress via protein overload thereby also influencing vital mitochondrial
functions. Calcium released from the ER augments the production of mitochondrial Reac-
tive Oxygen Species (ROS).Toxic accumulation of ROS within ER and mitochondria disturbs
fundamental organelle functions. Sustained ER stress is known to potentially elicit inflam-
matory responses via UPR pathways. Additionally, ROS generated through inflammation or
mitochondrial dysfunction could accelerate ER malfunction. Dysfunctional UPR pathways
have been associated with a wide range of diseases including several neurodegenerative
diseases, stroke, metabolic disorders, cancer, inflammatory disease, diabetes mellitus,
cardiovascular disease, and others. In this review, we have discussed the UPR signaling
pathways, and networking between ER stress-induced inflammatory pathways, oxidative
stress, and mitochondrial signaling events, which further induce or exacerbate ER stress.
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INTRODUCTION
Endoplasmic reticulum (ER) is a cardinal membrane-bound
organelle comprising of interconnected highly branched tubules,
vesicles, and cisternae. ER structure can be categorized as domains
like nuclear envelope domain (array of proteins that are synthe-
sized on rough ER and concentrated within the inner membrane),
the rough and smooth ER domain (due to presence and absence
of bound ribosomes respectively), and the regions that contact
other organelles like plasma membrane, Golgi, vacuoles, mito-
chondria, peroxisomes, late endosomes, and lysosomes (for ease
of direct transfer of lipids to their membranes and efficient calcium
signaling) (Voeltz et al., 2002). ER functions majorly in translocat-
ing and integrating proteins (secretory and membrane proteins
respectively), assisting their folding and transport (extracellular
or to cell membrane), lipid biosynthesis, and maintaining calcium
homeostasis. It is also a site for post translational modification
(N -linked glycosylation) of proteins and is considered as a sig-
naling organelle (Berridge, 2002; Fagone and Jackowski, 2009;
Sammels et al., 2010; Braakman and Bulleid, 2011). Ribosomes
embedded on rough endoplasmic reticulum (RER) are sites for
protein synthesis and secretion. Smooth endoplasmic reticulum
(SER) lacks bound ribosomes, therefore, inefficient in protein syn-
thesis but is important for fatty acid and phospholipids synthesis,
carbohydrate metabolism, lipid bilayer assembly, and regulation
of calcium homeostasis. Cell type, cell function, and cell needs
determine the role of ER in the cell. For example, liver cells high
in SER aid in drug detoxification; while plasma cells, beta cells,
and other secretory cells are rich in RER to meet their secretory
protein demand; sarcoplasmic reticulum, a specialized form of the
ER is more in muscle cells functioning in muscle contractions and
relaxation (Alberts et al., 2002).
The excursion of secretory or membrane protein begins at
ER. A protein destined to be modified in ER is marked with an
N-terminal ER signal sequence. During co-translational modifi-
cation, a signal recognition particle (SRP) recognizes and binds to
signal sequence on nascent protein, ribosome, and SRP receptor on
ER membrane, after which ribosome-nascent polypeptide chain
complex is rapidly transferred to a membrane protein translo-
cator, the SEC61 translocon. Signal peptide is cleaved by signal
peptidase on ER membrane and finally the nascent chain enters
the ER lumen via the translocon. In post translational modi-
fication, interaction of SEC61 translocon and completely syn-
thesized protein is sufficient for its ER targeting (Lodish et al.,
2000).
The proteins in ER are folded and modified under the vigilance
of ER resident molecular chaperones and folding enzymes that
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accelerate rate limiting reactions in protein folding mechanisms
and thus assist them in attaining appropriate conformation and
maturation. The glucose-regulated proteins (GRP) system includ-
ing chaperones of Hsp70 family and co-chaperones of HSP40
family (Kampinga and Craig, 2010), ER lectin-like chaperone sys-
tem including calnexin (CNX) and/or calreticulin (CRT) along
with glucosidases and transferases (Rutkevich and Williams,2011),
and finally the protein disulfide isomerase (PDI) family of disulfide
bond oxidase, reductase, and isomerase enzymes (Appenzeller-
Herzog and Ellgaard, 2008) are the pillars of Endoplasmic Retic-
ulum Quality Control system (ERQC). ERQC system has its par-
ticular vital role to play in converting a protein from nascent to
native state (Nishikawa et al., 2005; Bukau et al., 2006; Hebert and
Molinari, 2007; Araki and Nagata, 2011). The aptly folded proteins
are transported to Golgi via vesicular carriers and finally escorted
to their destinations (plasma membrane or lysosomal membrane
or loaded into granules for secretion) (Szul and Sztul, 2011). Selec-
tive chaperones of ERQC system and specific mannose lectins like
ER degradation-enhancing α-mannosidase-like protein (EDEM)
are capable of tagging unassembled, misfolded, or unfolded pro-
teins, which facilitates their identification and retrotranslocation
to cytosol via SEC61 translocon where they are steered to ubiquitin
proteasome degradation system or are eliminated by autophagic
degradation (Smith et al., 2011).
Here, we review the signaling events occurring within ER under
stressed conditions, its counter effect on other organelles, and
give crisp information on interaction between ER stress pathways,
oxidative stress, and inflammation.
UNFOLDED-PROTEIN RESPONSE
Accumulation of unfolded/misfolded/mutated proteins (Hetz and
Soto, 2006; Viana et al., 2012), disturbances in cellular redox regu-
lation and endogenous reactive oxygen species (ROS) production
(Fedoroff, 2006), hypoxia (Feldman et al., 2005; Sawada et al.,
2008), hyperglycemia, and hyperlipidemia (Fonseca et al., 2011;
Abbreviations: ADNF, activity-dependent neurotrophic factor; AIP1,
ASK1-interacting protein-1; ALS, amyotrophic lateral sclerosis; AMPA, α-
amino-3-hydroxy-5-methylisoxazole-4-propionate acid; AP-1, activator protein-1;
APR, acute phase response; ARD, ankyrin repeat domain; ASK1, apoptosis
signal-regulating kinase; ATF4, activating transcription factor 4; ATF6, activating
transcription factor 6; ATP, adenosine 5-triphosphate; Bad, Bcl-2-associated
death promoter; BAFF, B cell activating factor; BAPTA-AM, 1,2-Bis(2-
aminophenoxy)ethane-N,N,N ′,N ′-tetraacetic acid tetrakis(acetoxymethyl)ester;
Bcl2, B-cell lymphoma 2; Bcl xl, B-cell lymphoma-extra large; BHA, buty-
lated hydroxyanisole; Bim, B-cell lymphoma 2 interacting mediator of
cell death; BIP, immunoglobulin heavy chain binding protein; CDDO,
2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid; CDDO Me, methyl 2-cyano-3,12-
dioxooleana-1,9(11)dien-28-oate, Bardoxolone methyl; CEMB, cyano enone
of methyl boswellates; CHOP, CCAAT/enhancer-binding protein homologous
protein; CNX, Calnexin; CREB, cAMP response-element-binding; CRP, C-reactive
protein; CRT, Calreticulin; DTT, dithiothreitol; EDEM, ER degradation-enhancing
α-mannosidase-like protein; eIF2α, eukaryotic translation initiation factor; ER,
endoplasmic reticulum; ERAD, ER-associated degradation; ERKs, extracellular
signal-regulated kinases; ERO, ER membrane associated oxidoreductin; ERSE,
ER stress response element; ERQC, Endoplasmic reticulum quality control
system; FAD, Flavin adenine dinucleotide; FoxO1, fork head box O1; GLS,
Golgi-localization signal; GRP, glucose-regulated protein; GSH, glutathione; GSSH,
glutathione to oxidized glutathione; IBD, inflammatory bowel disease; IEC, intesti-
nal epithelial cells; IKK, IκB kinase; IAPs, inhibitor of apoptotic proteins; IL-1R, in-
terleukin 1-receptor; InsP3, inositol 1,4,5-triphosphate RyRs, ryanodine receptors;
Back et al., 2012), aberrations in calcium regulation (Gorlach et al.,
2006), viral infections (He, 2006; Zhang and Wang, 2012) act as
stress signals and alter ER homeostasis making it dysfunctional. In
response to such diverse signals, ER elicits a protective or adaptive
response called unfolded-protein response (UPR) with an aim to
restore ER homeostasis; however, if the stress signal is severe and/or
prolonged, ER triggers cell death pathways (Szegezdi et al., 2006;
Kim et al., 2008a; Cheng and Yang, 2011; Benbrook and Long,
2012).
Stress signals culminate in overloading ER with proteins and
exhausting the ER machinery. ER stress is thought to be and in cer-
tain cases proved to play a key role in diseases like Alzheimer’s dis-
ease (Salminen et al., 2009; Viana et al., 2012), Parkinson’s disease
(Wang and Takahashi, 2007; Cali et al., 2011), amyotrophic lateral
sclerosis (ALS) (Lautenschlaeger et al., 2012; Tadic et al., 2014),
poly glutamine diseases (Vidal et al., 2011), ischemia (Doroudgar
et al., 2009), atherosclerosis (Zhou and Tabas, 2013), bipolar dis-
order (Hayashi et al., 2009), prion diseases (Xu and Zhu, 2012),
cancer (Tsai and Weissman, 2010), diabetes (Papa, 2012), auto
immune disorders (Zhong et al., 2012), and cardiovascular dis-
orders (Minamino et al., 2010). Interestingly, there are reports
demonstrating that ER stress inhibition could protect against neu-
ronal injury (Qi et al., 2004; Sokka et al., 2007), ischemia (Nakka
et al., 2010), cardiovascular diseases (Teng et al., 2011), respira-
tory disorders (Hoffman et al., 2013), atherosclerosis (Zhou et al.,
2013), and sleep apnea (Zhu et al., 2008), in in vivo murine models.
THE MACHINERY OF UPR
The adaptive UPR comprises of signal transduction path-
ways initiated by ER proximal UPR transmembrane proteins:
inositol-requiring kinase 1 (IRE1α), activating transcription fac-
tor 6 (ATF6), and double-stranded RNA-activated protein kinase
(PKR)-like endoplasmic reticulum kinase (PERK) in an attempt
to restore homeostasis and normal ER functions (Schroder and
Kaufman, 2005). These UPR transducer proteins are negatively
IRAK2, interleukin-1 receptor-associated kinase-2; IRE1α, inositol-requiring
kinase 1; IRES, internal ribosome entry site; JAB1, Jun activation domain-binding
protein-1; JIK, c-Jun-N-terminal inhibitory kinase; LPS, lipopolysaccharides; MAM,
mitochondrial associated membranes; MAPK, mitogen activated protein kinase;
MAPKKK, mitogen activated protein kinase kinase kinase; MCP1, monocyte
chemoattractant protein-1; MM, multiple myeloma; NAC, N-acetyl-l-cysteine;
nACh, nicotinic acetylcholine; NDGA, nordihydroguaiaretic acid; NEMO, NF-
kappa-B essential modulator; NES, nuclear export sequence; NF-κB, nuclear factor
κB; NGF, nerve growth factor; NIK, NF-κB-inducing kinase; NLS, nuclear local-
ization signal; NMDA, N-methyl-d-Aspartate; NO, nitric oxide; NOD, non-obese
diabetic; Nrf2, nuclear erythroid 2 p45-related factor 2; Oasis, old astrocyte specif-
ically induced substance; PBA, 4-phenylbutyrate; PDI, protein disulfide isomerase;
PDTC, pyrrolidine dithiocarbamate; PERK, double-stranded RNA-activated pro-
tein kinase (PKR)-like endoplasmic reticulum kinase; RER, rough endoplasmic
reticulum; RHR, Rel homology region; RIP, regulated intramembrane proteolysis;
RNS, reactive nitrogen species; ROI, reactive oxygen intermediates; ROS, reac-
tive oxygen species; S1P, site-1 protease; S2P, site-2 protease; SAP, serum amyloid
P-component; sAPP, secreted ß-amyloid precursor protein; SER, smooth endo-
plasmic reticulum; SERCA, Sarco/ER calcium-ATPase; SOD, superoxide dismu-
tase; SRP, signal recognition particle; sXBP1, spliced XBP1; TAD, transcription
activation domain; TCA, tricarboxylic acid; TLR, Toll-like receptor 4; TMB-8,
3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester; TNFR, tumor necrosis
factor receptor; TRAF2, tumor necrosis factor receptor-associated factor 2; TUDCA,
taurine-conjugated ursodeoxycholic acid; UPR, unfolded-protein response; XBP1,
X-box-binding protein 1.
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FIGURE 1 | Unfolded protein response pathways are shown. The newly
synthesized protein destined for modification in ER enters through SEC61
channel and undergoes folding and maturation. Under basal/unstressed
conditions, the BIP (immunoglobulin heavy chain binding protein) binds to
ATF6 (activating transcription factor 6), IRE1α (inositol-requiring kinase 1),
and PERK [double-stranded RNA-activated protein kinase (PKR)-like
endoplasmic reticulum kinase] thereby inhibiting them. During ER stress,
BIP dissociates from the three UPR sensors and binds to unfolded/misfolded
proteins, thus initiating adaptive signaling events to help ER recover from
the stress. Dissociation of BIP from ATF6 unmasks a Golgi-localization signal
(GLS, not shown here), which facilitates its translocation to Golgi where it
undergoes regulated intramembrane proteolysis (RIP) by resident proteases,
Site-1 protease (S1P) and Site-2 protease (S2P). The released ATF6 acts as a
transcription factor, which travels to the nucleus and binds to ER-stress
response elements (ERSE) and induces transcription of several genes,
including BIP, CHOP (CCAAT/enhancer-binding protein homologous protein),
and X-box-binding protein 1 (XBP1). Similarly IRE1α is activated and
undergoes homodimerization and autophosphorylation, thereby activating
the endoribonuclease activity, which splices XBP1 mRNA to spliced XBP1
mRNA, which codes for a transcription factor XBP1s that translocates to
nucleus and regulates genes involved in UPR and ER-associated degradation
(ERAD). Finally, the release of BIP activates PERK pathway, which initiates a
global translational arrest by phosphorylating the translation initiation factor
2α (EIF2α), thus decreasing ER protein load. ATF4 (Activating Transcription
Factor 4) mRNA escapes translational suppression exclusively as it
possesses internal ribosome entry site (IRES) sequences in the
5′-untranslated regions. ATF4 enters nucleus and regulates expression of
UPR target genes.
regulated by the chaperone GRP78/BIP (immunoglobulin heavy
chain binding protein) in unstressed or healthy ER at their lumi-
nal ends (amino terminal), however, increase in unfolded proteins
causes dissociation of Grp78/BIP thereby releasing the inhibition
and thus eliciting the response (Bertolotti et al., 2000; Pfaffenbach
and Lee, 2011) (Figure 1).
THE IRE1α PATHWAY
Homo-oligomerization of activated IRE1α opens the Ser/Thr
kinase domain at the cytosolic carboxyl terminal, aligning it for
trans-autophosphorylation thereby activating the endoribonucle-
ase domain (Shamu and Walter, 1996; Sidrauski and Walter, 1997;
Liu et al., 2003). X-box-binding protein 1 (XBP1) mRNA is spliced
unconventionally by this RNAase domain of IRE1α; cleaving a
26 nucleotide intron to produce a spliced mRNA that codes for
bZIP-family transcription factor sXBP1 (spliced XBP1). Once it
is translocated to the nucleus, it can dimerize or act in tandem
with other co-regulators and regulate several genes involved in
UPR and ER-associated degradation (ERAD) by binding to ER
stress response element (ERSE) promoter (Yoshida et al., 1998,
2001a; Lee et al., 2003; Van Huizen et al., 2003). The dimerized
and activated IRE1α collaborates with modulators and adaptors
on the cytosolic end to initiate signaling events in response to
the intensity and duration of stress. Adaptor-like tumor necrosis
factor receptor (TNFR)-associated factor 2 (TRAF2), an E3 ubiq-
uitin ligase, recruits apoptosis signal-regulating kinase (ASK1), a
mitogen-activated protein kinase kinase kinase (MAPKKK) that
has been shown to relay various stress signals to the downstream
MAPKs consequently activating Jun N-terminal kinase (JNK) and
p38 MAP kinase (Derijard et al., 1995; Urano et al., 2000; Nishitoh
et al., 2002). IRE1α also triggers activation of other kinases such
as extracellular signal-regulated kinases (ERKs) as well as nuclear
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factor κB (NF-κB) pathways (Kaneko et al., 2003; Nguyen et al.,
2004; Hu et al., 2006).
THE PERK PATHWAY
Double-stranded RNA-activated protein kinase (PKR)-like endo-
plasmic reticulum kinase, another UPR mediator, also undergoes
similar dimerization and autophosphorylation (Ma et al., 2002a)
to initiate a transient cellular translational arrest by phosphory-
lating at serine residue 51 and inactivating eukaryotic translation
initiation factor (eIF2α) (Harding et al., 1999), the most stud-
ied and well-known substrate of PERK, thereby reducing protein
load on ER and causing cell-cycle arrest (Brewer and Diehl, 2000).
However, the phosphorylated eIF2α can translate genes with inter-
nal ribosome entry site (IRES) sequences in the 5′-untranslated
regions sidestepping the eIF2α translational block (Vattem and
Wek, 2004; Schroder and Kaufman, 2005); one such gene being
ATF4, which encodes ATF4 (Activating Transcription Factor 4), a
member of the cAMP response-element-binding (CREB) family
of transcription factors (Lu et al., 2004) that induces expres-
sion of several genes central in cell survival and UPR (Harding
et al., 2000a,b, 2003; Scheuner et al., 2001; Ma et al., 2002b;
Raven et al., 2008). This PERK-mediated translational block is
also essential for activation of NF-κB (Jiang et al., 2003). One
of the downstream substrate of PERK is Keap1, which sequesters
the nuclear erythroid 2 p45-related factor 2 (Nrf2) in cytoplasm.
PERK phosphorylates Keap1, thereby freeing Nrf2 of inhibition
and facilitating its nuclear import for expression of antioxidant
and detoxification enzymes (Cullinan et al., 2003; Cullinan and
Diehl, 2006).
THE ATF6 PATHWAY
Release of GRP78, unmasks the Golgi-localization signal (GLS),
forms ER membrane tethered ATF6 proteins expediting their
translocation to the Golgi (Chen et al., 2002); where they undergo
regulated intramembrane proteolysis (RIP) by resident proteases
Site-1 protease (S1P) and Site-2 protease (S2P) (Ye et al., 2000)
cleaving at a juxtamembrane site, producing and releasing active
ATF6 transcription factors into the cytosol (Haze et al., 1999).
They will then migrate into the nucleus and homodimerize or
heterodimerize with other transcription factors to regulate gene
expression of proteins involved in UPR (Yoshida et al., 1998, 2001b;
Yamamoto et al., 2007; Adachi et al., 2008). Not a long ago, new
membrane-bound bZIP transcription factors were identified with
similar structural and proteolysis pattern as ATF6. These include
Luman (CREB3), Oasis (old astrocyte specifically induced sub-
stance, CREB3L1), BBF2H7 (CREB3L2), CREBH (CREB3L3), and
Tisp40 (CREB4, CREB3L4) (Bailey and O’Hare, 2007). Regardless
of structural similarity with ATF6, these factors execute distinctive
functions in regulating UPR based on activating stimuli/stress,
cell type, and response element binding (Asada et al., 2011).
CREBH, a liver-specific transcription factor does not serve as a
UPR transactivator for expression of classic ER chaperone genes
regulated under ERSE; however, it modulates ER stress response
genes that contain ERSE in their promoter regions. CREBH is
cleaved upon ER stress thereby activating expression of acute
phase response (APR) genes like those encoding serum amyloid
P-component (SAP) and C-reactive protein (CRP) providing a
correlation between ER stress and acute inflammatory responses
(Zhang et al., 2006).
Thus, all the three UPR sensors are regulated by one master
regulator, i.e., GRP78/BIP (Hendershot, 2004). The mission of ER
under stress is to thus increase the expression of transcription fac-
tors, which orchestrates and initiates production of ER chaperones
and genes involved in ERAD, to provide tolerance to the stress and
restore homeostasis. Thus, ER mandatorily has to be dynamic to
meet its changing needs, which are managed by integrated signal-
ing pathways that constantly monitor the levels of ER machinery.
If the UPR is incompetent to abolish the stress, ER prompts a
cell death program, which can be apoptotic (Szegezdi et al., 2006;
Tabas and Ron, 2011; Gorman et al., 2012), non-apoptotic (Ull-
man et al., 2008), or autophagic (Ogata et al., 2006; Yorimitsu
et al., 2006; Ullman et al., 2008; Cheng and Yang, 2011) therefore
resulting in cellular demise (Heath-Engel et al., 2008; Benbrook
and Long, 2012; Logue et al., 2013).
INTEGRATION OF ER STRESS AND OTHER PATHWAYS IN
NEURODEGENERATION
The major cellular communicating compartments include
nucleus, ER, mitochondria, and Golgi that initiate signaling path-
ways to help the cell respond to various intracellular and extra-
cellular signals/stresses. Besides UPR, other pathways emanating
from ER collaborate with mitochondria and nucleus to regu-
late the cellular responses (Figure 2). The interaction among
reactive species formation, disturbed calcium homeostasis, mito-
chondrial collapse, and inflammation is a common phenome-
non existing in various disorders and its connection with ER
stress is recently being explored and demands more research. The
complications underlying neurodegenerative disorders are multi-
factorial and may include genetic predisposition (Bertram and
Tanzi, 2005; Lill and Bertram, 2011), environmental factors (Can-
non and Greenamyre, 2011), cellular stressors such as oxidative
stress and free radical production (Gandhi and Abramov, 2012),
excitotoxicity (Dong et al., 2009), neuroinflammation (Glass et al.,
2010), disruption of calcium-regulating systems (Bezprozvanny,
2009), mitochondrial dysfunction (Lezi and Swerdlow, 2012), and
misfolded protein accumulation (Matus et al., 2011).
Central nervous system being most aerobic includes neurons,
which are differentiated and are highly mitochondrial dependent.
They require massive amount of adenosine 5-triphosphate (ATP);
to satisfy their tremendous metabolic demands, for maintaining
ionic gradients across the cell membranes and for neurotransmis-
sion, thereby being very sensitive to mitochondrial stress (Ames,
2000; Nicholls and Budd, 2000). Mitochondria are known to play
a central role in many vital cell functions including generation
of cellular energy in the form of ATP, maintaining intracellular
calcium homeostasis, ROS formation, apoptosis, fatty acid oxida-
tion, and steroid synthesis. Mitochondrial stress characterized by
abnormal mitochondrial morphology, biochemical dysfunction,
and disturbed redox homeostasis is a common manifestation in
brain aging and several chronic neurodegenerative diseases like
Alzheimer’s disease, Parkinson’s disease, ALS, and Huntington’s
disease (Beal, 2005; Lezi and Swerdlow, 2012). Likewise, mito-
chondrial dysfunction is also predominant in pathogenesis of
cancer, cardiovascular diseases, and several metabolic diseases like
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FIGURE 2 | A loop of oxidative stress, ER stress leading to
inflammation. During protein overload, ROS are generated in the ER as a
part of an oxidative folding process during electron transfer between protein
disulfide isomerase (PDI) and endoplasmic reticulum oxidoreductin-1
(ERO-1). ROS can target ER resident proteins, enzymes, and chaperones
(not shown) and ER based calcium (Ca2+) channels, leading to the release of
calcium from the ER into the cytosol and ER-stress signaling. Increased
cytosolic calcium and calcium entry in mitochondria from ER via
MAM-associated channels can stimulate mitochondria metabolism to
produce more ROS. Increased mitochondrial calcium concentration causes
cytochrome c release, altered membrane potential that eventually triggers
cellular death programs. The increased protein folding demand, calcium and
ROS signaling integrates with UPR pathways and can potentially lead to
inflammatory responses.
obesity, insulin resistance, and diabetes (Lesnefsky et al., 2001;
Wallace, 2005; Kim et al., 2008b; Mantena et al., 2008; Hu and Liu,
2011).
Mitochondria have a noteworthy role in neurodegenerative dis-
eases,where various disease-specific proteins (misfolded/mutated)
interact with mitochondria and/or affect mitochondrial function
(Johri and Beal, 2012). There are emerging evidences suggesting
that triggering of UPR pathways by cellular and/or extracellular
accumulation of misfolded/aberrant proteins in several human
neurodegenerative conditions could cause severe loss in neuronal
functions and viability (Doyle et al., 2011; Bernales et al., 2012).
In addition, imbalance in Ca2+ homeostasis, which is signifi-
cant in neurodegenerative diseases affects mitochondria and ER
as they are physically and functionally tightly interconnected via
mitochondrial-associated membranes (MAM), which participates
in Ca2+ signaling, lipid transport, energy metabolism, and cell
survival. Thus, apart from coordinating pathways involved in cell
life and death, their physical association is vital and any loss of
communication in them is known to complicate and worsen the
prevailing conditions in neurodegenerative diseases (Malhotra and
Kaufman, 2011; Vannuvel et al., 2013).
CALCIUM LINKS ER AND MITOCHONDRIA
In the brain, calcium participates in various intracellular and
extracellular processes and its fluctuations across the plasma mem-
brane and between intracellular compartments play crucial roles
in integral functions of neurons like neuronal excitability, synaptic
transmission and plasticity, memory formation, neurotransmitter
release, activation of specific calcium-dependent signal transduc-
tion pathways, and gene transcription (Berridge, 1998). The free
cytosolic calcium levels in neurons are maintained around 0.1–
0.5µM, while the extracellular levels being ~1 mM. On encoun-
tering stimulatory signals, extracellular calcium influx or calcium
release from intracellular stores is triggered. Calcium can enter
the neuronal cell by voltage-operated channels or by receptor-
operated channels, on the plasma membrane controlled by neuro-
transmitters. Later includes glutamate receptors like N -methyl-
d-aspartate (NMDA), α-amino-3-hydroxy-5-methylisoxazole-4-
propionate acid (AMPA), kainic acid, nicotinic acetylcholine
(nACh), serotonin (5-HT3) and adenosine 5-triphosphate (ATP)
P2X receptors. Na-K-ATPase and Ca2+-ATPases maintain ionic
gradient along the neuronal membrane at the expense of consid-
erable amounts of ATP. The main intracellular calcium store is the
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ER (10–100 mM),acting as a major buffering system that functions
as a sink for Ca2+ storage, from where calcium can be released into
the cytosol via activation of the inositol 1,4,5-triphosphate recep-
tors [InsP3Rs, sensitive to inositol 1,4,5-triphosphate (InsP3)] or
ryanodine receptors (RyRs, sensitive to cyclic ADP ribose). Both
the InsP3Rs and the RYRs are also sensitive to Ca2+, and this
process of calcium-induced calcium release can set up propa-
gated calcium waves. Resting cytosolic calcium levels are partly
maintained by calcium-binding and calcium-buffering proteins
(e.g., calmodulin, calcineurin, calretinin, calbindin, or parvalbu-
min) or by active uptake into internal stores by the Sarco/ER
calcium-ATPase (SERCA) at the ER membrane or by the mito-
chondrial uniporter. Minor transient alterations in calcium levels
occurring during physiological processes are salient to neuronal
functioning; however, pathological conditions accompanied by
prolonged increase in calcium levels can overwhelm the calcium
regulatory network, making the cell difficult to recuperate. Ram-
pant fluctuations in this highly regulated calcium homeostasis not
only disturbs normal brain physiology but also hampers neuronal
integrity and viability (Kawamoto et al., 2012). An accumulation
of misfolded proteins in the ER lumen can cause leaky calcium
efflux from the ER, possibly via inositol-triphosphate receptors
(Deniaud et al., 2008). Additionally during Ca2+ overload, calcium
influx increases in mitochondria and ER, thereby causing changes
in mitochondrial pH and ROS production accompanied by altered
mitochondrial membrane potential and opening of permeability
transition pore with subsequent release of cytochrome c, cardi-
olipin peroxidation, and activation of several calcium-dependent
proteins and kinases (Smaili et al., 2009). Thus, calcium-induced
ROS increase and ROS-mediated calcium vulnerability create a
self amplifying loop (Peng and Jou, 2010).
In the adaptive phase of UPR, ER-to-mitochondria Ca2+ trans-
fer under regulation by MAM proteome maintains mitochondrial
metabolism and ATP production that safeguards cellular func-
tions. However, severe ER stress induces mitochondrial Ca2+
overload, ROS accumulation, and ATP depletion and thus acti-
vates the mitochondria-dependent apoptosis (Raturi and Simmen,
2013). Prolonged stimulation of neuronal glutamate receptors
results in excitotoxicity due to massive calcium influx activating
several enzymes and proteases eventually causing neuronal loss
in neurodegenerative diseases. This is accompanied by excessive
nitric oxide (NO) production by neuronal NO synthase (Calabrese
et al., 2000; Dong et al., 2009). Significant loss in PDI function
due to NO-mediated S-nitrosylation causes dysregulated protein
folding and accumulation of polyubiquitinated proteins leading
to neuronal death via ER stress. This was backed up by the fact
that S-nitrosylated PDI was found in neurodegenerative diseased
brains suggesting ER dysfunction as critical factor that relates NO-
induced cellular stress to neurodegeneration (Uehara et al., 2006).
Chen et al. (2013) identified NO-mediated S-nitrosylation of PDI
as one of the liable factors for accumulation of mutant superoxide
dismutase (SOD) 1 aggregates in ALS.
OXIDATIVE STRESS IN ER AND MITOCHONDRIA
Free radicals are generated from two sources: the UPR-regulated
oxidative folding machinery in the ER (Bhandary et al., 2012)
and mitochondria (Cadenas and Davies, 2000). ROS and reactive
nitrogen species (RNS) are byproducts of normal cellular metab-
olism and are also produced in response to multiple stresses in
various compartments of cell by enzymatic or non-enzymatic
processes. ROS and RNS are known to play dichotomous role as
being both harmful at high concentrations while beneficial at mod-
erate/low concentrations and in harmony with cellular antioxidant
defense mechanisms that they maintain cellular redox homeostasis
(Calabrese et al., 2000; Finkel, 2011; Dasuri et al., 2013). Oxidative
stress is a condition in which the production of reactive species
is alarmingly high and the available antioxidant defenses is lim-
ited; resulting in damage to DNA, proteins, sugars, and lipids by
the excessive free radicals (Valko et al., 2007). Superoxide anion
(triplet stage molecular oxygen) produced majorly in mitochon-
dria is a primary ROS and is a precursor for many secondary ROS,
including hydrogen peroxide, hydroxyl radical, hypochlorous acid,
and hydroperoxyl radical. Similarly nitric oxide is produced during
arginine metabolism and can be converted to various other RNS
such as nitrosonium cation, nitrite and nitrate radical, nitroxyl
anion, or peroxynitrite. Complexes I and III of mitochondrial
respiratory chain and α-ketoglutarate dehydrogenase in the tricar-
boxylic acid (TCA) cycle contribute to ROS production. There also
exist mitochondrial enzymes that detoxify/scavenge free radicals
(Stamler et al., 1992; Turrens, 2003).
Endoplasmic reticulum provides an exclusive oxidizing-folding
environment to the proteins to facilitate disulfide bond formation
and this process is believed to contribute to 25% of ROS generated
by cell (Tu and Weissman, 2004; Malhotra and Kaufman, 2007).
PDI, a member of the thioredoxin superfamily catalyzes disulfide
bond formation through thiol-disulfide oxidation, reduction, and
isomerization. A flavin adenine dinucleotide (FAD)-dependent
reaction is carried out by ERO-1 (ER membrane associated oxi-
doreductin) involving transfer of electrons from reduced PDI to
molecular oxygen (O2), resulting in ER protein folding-induced
oxidative stress. Erroneous disulfide bonds are reduced by glu-
tathione (GSH) thereby decreasing the reduced glutathione to
oxidized glutathione (GSSH) ratio and altering the redox envi-
ronment in the ER. The ER ratio of GSH/GSSH ranges from 1:1
to 3:1, while the cellular ratio ranges from 30:1 to 100:1. Lastly, ER
transmembrane protein NADPH oxidase complex, Nox4 is also
involved in producing superoxide anion and hydrogen peroxide
(Hwang et al., 1992; Santos et al., 2009).
ER STRESS AND INFLAMMATION
Endoplasmic reticulum stress and inflammation are related in a
way that under acute trigger, they safeguard the cellular viability
and functions and when chronically induced they are destructive
and go beyond physiological control. Recent research reveal con-
nections at multiple levels between UPR and inflammation and
therefore focuses are now deviated to understand involvement of
ER stress in specialized cells and tissues concerning inflammatory
and immune responses. ER stress-induced inflammation primar-
ily serves to limit the tissue damage and facilitate tissue repair;
however, it largely depends on the target cell type, the disease stage,
and the type of ER stressor. Several inflammatory chronic diseases
including diabetes, obesity, neurodegenerative diseases, athero-
sclerosis, arthritis, respiratory diseases, irritable bowel syndrome,
cardiovascular diseases, cancer, and many metabolic diseases have
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ER stress as factor involved in progression of the disease (Pahl
and Baeuerle, 1995; Zhang and Kaufman, 2008; Garg et al., 2012;
Verfaillie et al., 2013).
NF-κB – A KEY PLAYER IN MEDIATING INFLAMMATORY RESPONSE
NF-κB plays an essential role of transcriptional regulator in medi-
ating inflammatory responses, immune and stress responses, and
regulates apoptosis, proliferation, differentiation, and develop-
ment. Under various stimulatory conditions by inflammatory
cytokines, viral and bacterial infections, or physical trigger by UV
irradiation or cellular physiological stresses, NF-κB is activated
and NF-κB target genes are expressed. NF-κB is a dimeric protein
comprising of different combinations of five Rel family mem-
bers [p65 (RelA), RelB, c-Rel, p105/p50 (NF-κB1) and p100/52
(NF-κB2)] therefore forming homo or heterodimers. They con-
tain a conserved ~300 amino acid region called Rel Homology
Region (RHR), which is composed of DNA-binding domain at its
N-terminal, followed by a short flexible linker, C terminal dimer-
ization domain, and finally a nuclear localization signal (NLS) that
completes the RHR. p65/RelA, c-Rel, and RelB, contain a tran-
scription activation domain (TAD) beyond the RHR at extreme
carboxy terminal ends and are responsible for transcribing NF-
κB target genes. Consequently, NF-κB dimers having minimum
one of them (p65/RelA, c-Rel, and RelB) are active transcrip-
tion factors. NF-κB dimers solely made of p50 and p52 subunits
repress transcription since they lack TAD, inspite of being capa-
ble of nuclear localization and DNA binding. Unless required,
NF-κB is sequestered in cytoplasm in its inactive form by consti-
tutively expressing inhibitors of NF-κB (IκB: IκBα, IκBβ, IκBε) and
is activated by signal-induced phosphorylation and consequential
proteosome degradation of inhibitor by IκB kinase (IKK). IκBα,
IκBβ, and IκBε contain a central ankyrin repeat domain (ARD),
which has conserved serine residues for phosphorylation by IKK
and also conserved lysine amino acids for poly-ubiquitination at its
amino terminal. IκBα exclusively has a functional nuclear export
sequence (NES), which is not masked on binding to NF-κB there-
fore restrains the complex NF-κB:IκBα to cytoplasm. NF-κB:IκBβ
complexes can reside stably in either nucleus or cytoplasm. IκBε
and IκBα are found to function as negative feedback regulators
for NF-κB escorting it back to cytoplasm (Arenzana-Seisdedos
et al., 1995; Kearns et al., 2006). All the three inhibitors of NF-
κB at their carboxy terminal ends have a short sequence rich in
the amino acids proline, glutamic acid, serine, and threonine. NF-
κB precursor’s p100 and p105 are also inhibitors of NF-κB in an
entire different fashion involving multiprotein assemblies. Disso-
ciation of IκB from NF-κB unmasks NLS, which facilitates NF-κB’s
translocation in nucleus thereby transcribing NF-κB target genes
involved in inflammatory responses. The IKK is composed of
three subunits: IKKα and IKKβ are legitimate kinases while IKKγ
(NEMO, NF-kappa-B essential modulator which interacts with
IKKβ) is known to play a regulatory role instead. The canoni-
cal pathway involves activation of cytokine receptors [(TNFR),
interleukin 1 (IL-1) receptor (IL-1R)], antigen receptors and
pattern-recognition receptors, Toll-like receptor 4 (TLR4), and
subsequent phosphorylation of IκBα by IKKβ and NEMO thereby
freeing mostly p65-containing heterodimers for nuclear translo-
cation. The alternative or non-canonical pathways are triggered by
activation of specific members of the TNF cytokine family, such as
CD40 ligand, B cell activating factor (BAFF) and lymphotoxin-β
following IKKα-mediated processing of precursor protein p100 to
p52 forming active p52–RelB complexes. NF-κB-inducing kinase
(NIK) is known to activate IKKα, whereas IKKβ can be activated
by multiple kinases (Dixit and Mak, 2002; Hayden and Ghosh,
2008; Huxford and Ghosh, 2009; Lawrence, 2009; Oeckinghaus
et al., 2011).
THE ER STRESS AS A TRIGGER FOR INFLAMMATION
Pahl and Baeuerle in 1995 demonstrated that NF-κB as a mix-
ture of p5O/p65 and p5O/c-rel heterodimers, functions in a
novel ER-nucleus signal transduction pathway upon gradual
accumulation of proteins in ER caused by over expression of
the immunoglobulin µ heavy chains. Similarly, tunicamycin, 2-
deoxyglucose, brefeldin A, and thapsigargin are capable of eliciting
UPR (grp induction) and activating NF-κB. However, castanosper-
mine (glucosidase inhibitor) and dithiothreitol (DTT) potentially
activate the UPR but not the NF-κB pathway; and tumor necro-
sis factor α (TNFα) and p65 over expression activate NF-κB
but not the UPR. On the other hand, synthetic triterpenoids
such as 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO),
Methyl 2-cyano-3,12-dioxooleana-1,9(11)dien-28-oate, Bardox-
olone methyl (CDDO-Me) and cyano enone of methyl boswellates
(CEMB) have been known to induce UPR and block the NF-
κB signaling (Zou et al., 2008; Ravanan et al., 2011a,b). Another
interesting finding was that preincubation with the antioxidant
pyrrolidinedithiocarbamate (PDTC) inhibited the NF-κB acti-
vation induced by tunicamycin, 2-deoxyglucose, and brefeldin
A implicating oxidative stress as a trigger for NF-κB activation
(Pahl and Baeuerle, 1995). In their further research, they found
that ER stress-mediated NF-κB activation depends on ER cal-
cium efflux (by thapsigargin or cyclopiazonic acid), followed by
formation of reactive oxygen intermediates (ROI). Preincuba-
tion with calcium chelators like 1,2-bis(2-aminophenoxy)ethane-
N,N,N ′,N ′-tetraacetic acid tetrakis(acetoxymethyl)ester (BAPTA-
AM) and 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl
ester (TMB-8); and antioxidants like N -acetyl-l-cysteine (NAC),
butylated hydroxyanisole (BHA), rotenone, nordihydroguaiaretic
acid (NDGA), DTT, and pyrrolidine dithiocarbamate (PDTC, to
less extent) blocked NF-κB activation. In addition, calcium chela-
tors inhibited ROI formation in response to thapsigargin and
cyclopiazonic acid, implying that calcium release precedes ROI for-
mation ultimately mediating ER overload-dependent NF-κB acti-
vation. Use of tepoxalin showed that ROI production was a result
of cyclooxygenases or lipoxygenases in response to thapsigargin
(Pahl and Baeuerle, 1996, 1997).
The close link between ER stress and inflammation is a likely
contributor to the integration of ER function and metabolic
homeostasis, considering the significant role of inflammation in
metabolic diseases (Hotamisligil, 2006). For instance, leptin (an
important adipokine acts on receptors in the hypothalamus of
the brain where it inhibits appetite) resistance has been known
to cause obesity and interestingly ER stress has been found to
induce leptin resistance (Hosoi et al., 2008). Non-obese diabetic
(NOD) mice exhibited dysfunction of the islet β-cell and glar-
ing ER stress prior to onset of hyperglycemia in type 1 diabetes
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conditions. Several fold increase in NF-κB target genes indicated
clear crosstalk between ER stress, cytokine signaling, and inflam-
mation defining the loss of β-cells and their functions in NOD
mice (Tersey et al., 2012). Pre-existing ER stress though mild, sen-
sitizes the pancreatic cells to weak inflammatory stimulus causing
an aggravated inflammatory response and accelerating the devel-
opment of type 1 diabetes. Miani et al. (2012) showed involvement
of ER stress specifically IRE1α-XBP1 pathway in NF-κB activation
and expression of its target genes via modulation of fork head
box O1 (FoxO1) protein concluding that β-cell-ER stress triggers
exacerbated local inflammation. ER-stressed smooth muscle cells
locally boost leukocyte adhesion by forming a hyaluronan rich
extracellular matrix promoting inflammatory responses (Majors
et al., 2003). Paneth and Goblet cells of intestinal epithelium
are XBP1-dependent for survival and to execute their secretory
functions. Intestinal inflammation in inflammatory bowel disease
(IBD) emerges from dysfunction in these cells due to excessive
ER stress, which may be an after effect of broad range of factors
like primary genetic (abnormalities in UPR, XBP1) and secondary
(inflammation, environmental) (Kaser and Blumberg, 2009; Kaser
et al., 2011). There exist some complex connections between ER
stress and inflammatory responses, which are cell type or condi-
tion specific and vary with different metabolic conditions causing
vivid increase in inflammatory mediators. All the three sensors of
UPR pathway are capable of NF-κB activation (Hotamisligil, 2010)
(Figure 3).
IRE1α–NF-κB
ER stress-induced activation of IRE1α kinase activity recruits
adaptor protein TNF receptor-associated factor 2 (TRAF2), c-
Jun-N-terminal inhibitory kinase (JIK), Jun activation domain-
binding protein-1 (JAB1), and ASK1-interacting protein 1 (AIP1)
to initiate downstream signaling pathways. IRE1α decides the
cellular fate, i.e., survival via UPR or death via apoptosis; regu-
latory mechanisms of which are not yet entirely understood. JAB1
was suggested to be a decisive molecule: interacting with IRE1α
under weak ER stress stimulation to suppress UPR and dissoci-
ating to allow IRE1α activation and the UPR under strong ER
FIGURE 3 | Endoplasmic reticulum stress-associated NFκB
activation is shown. ER stress-induced activation of IRE1α kinase
activity recruits adaptor protein tumor-necrosis factor-α (TNF-α)
receptor-associated factor 2 (TRAF2), which further recruits c-Jun
N-terminal kinase (JNK) activating several transcription factors and many
apoptosis signaling proteins. JNK induces the expression of
inflammatory genes by phosphorylating the transcription factor activator
protein 1 (AP-1), which is a dimer of monomers from various protein
families forming different combinations of AP-1. They induce
inflammation via promoting transcription of genes for cytokines,
chemokines, and other proinflammatory molecules. TRAF2 associates
with IκB kinase (IKK) activating NF-κB by promoting degradation of IκBα
resulting in NF-κB nuclear translocation. PERK branch of UPR also can
potentially induce NF-κB not by IκBα phosphorylation or degradation but
essentially by its eIF2α-mediated attenuation of translation; successively
inhibiting the synthesis of IκBα. Subtilase cytotoxin from Shiga strain of
E. coli makes a specific single site cleavage in GRP78, therefore capable
of eliciting ER stress response pathways. CREBH and ATF6 may
dimerize and synergistically activate transcription of major APR genes
inducing a systemic inflammatory response in specific cells.
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stressed conditions (Oono et al., 2004). Activated IRE1α recruits
adaptor protein TRAF2, and c-JNK activation is followed. Domi-
nant negative TRAF2 with a truncated N-terminal RING effector
domain inhibited JNK activation via IRE1α (Urano et al., 2000).
In response to ER stress-inducing agents like thapsigargin and
tunicamycin, IRE1α–TRAF2 pathway is known to induce NF-κB
activation, which is inhibited by both dominant negative IRE1α
and TRAF2 (Leonardi et al., 2002; Kaneko et al., 2003). Hu et al.
(2006) reported that the ER stress inducers induce IRE1α to form
a complex with IKK essentially through TRAF2, thereby acti-
vating NF-κB by promoting degradation of IκBα resulting in
NF-κB nuclear translocation. This was accompanied by upreg-
ulation of TNFα (but not FasL and TRAIL) in an IRE1α- and
NF-κB-dependent manner (not via TNFR1 signaling) and down-
regulation of TRAF2, which weaken TNFα-induced activation
of NF-κB and JNK, and triggered TNFα-induced apoptosis. JIK
binds to both TRAF2 and IRE1α, causing increase in JNK acti-
vation under ER stress, thus modulating IRE1α–TRAF2 signaling
events. TRAF2 also interacts with procaspase-12 under ER stress
thereby promoting clustering and cleavage to its active caspase-12
form and initiating apoptotic signaling pathways (Yoneda et al.,
2001). Luo et al. (2008) using AIP1 knockout cells concluded that
AIP1 is involved in ER stress-activated IRE1α–JNK/XBP1 pathway
and that IRE1α–AIP1 complex is essential for subsequent recruit-
ment of TRAF2 to IRE1α. JNK, member of the mitogen activated
protein kinase (MAPK) superfamily, phosphorylates and activates
several transcription factors such as c-Jun, ATF2, p53, c-Myc, and
many apoptosis signaling proteins like Bcl-2, Bcl-xL, Bad, and Bim
(Bogoyevitch and Kobe, 2006). Activated JNK induces the expres-
sion of inflammatory genes by phosphorylating the transcription
factor activator protein 1 (AP1), which is a dimer of monomers
from various protein families like JUN, FOS, ATF, and MAF which
interact to form different combinations of AP-1 (Davis, 2000).
The various genes that are regulated by AP-1 are combination
specific and execute different biological functions. They induce
inflammation via promoting transcription of genes for cytokines,
chemokines, and other proinflammatory molecules (Angel et al.,
2001; Shaulian and Karin, 2001; Eferl and Wagner, 2003).
Knockdown experiments unveiled that loss of either IRE1α
or PERK curtailed NF-κB signaling in ER stress pathways, sig-
nifying combinatorial and synergistic effect of both sensors for
complete NF-κB activation. IRE1 (kinase domain)-TRAF2–IKK
signaling, not via JNK, leads to ER stress-induced NF-κB activation
(Tam et al., 2012). Spliced XBP1 and ATF4, induce production of
the inflammatory cytokines/chemokines IL-8, IL-6, and monocyte
chemoattractant protein 1 (MCP1) in human aortic endothelial
cells (Gargalovic et al., 2006). Malfunctioning of Paneth cells and
heightened proinflammatory response in XBP1-deficient intesti-
nal epithelial cells (IEC) provided evidence of XBP1 anomalies in
IEC as being exclusively responsible for intestinal inflammation
(Kaser et al., 2008).
PERK–NF-κB
PERK branch of UPR can potentially induce NF-κB essentially by
its eIF2α-mediated attenuation of translation; successively inhibit-
ing the synthesis of IκBα. It was also found that half life of this
inhibitor is less compared to NF-κB culminating in increased ratio
of NF-κB to IκB, which facilitates NF-κB’s nuclear translocation to
activate its target genes in response to ER stress (Deng et al., 2004).
Comparable results were also obtained by Wu et al. (2004), which
demonstrated that ultraviolet light inhibits new IκBα synthesis
that can be reversed by expression of an eIF2α (S51A) mutant.
ATF6–NF-κB
Subtilase cytotoxin from Shiga strain of E. coli is a serine protease,
which enters the cell and makes a specific single site cleavage in
GRP78 (Paton et al., 2006). This causes the GRP78 to dissociate
from the ER stress sensors and activate an early ER stress response
qualitatively similar to that observed with the certified UPR-
inducing chemical agents (Wolfson et al., 2008). Yamazaki et al.
(2009) made a significant contribution by dissecting the UPR
pathways involved in subtilase triggered NF-κB activation. The ini-
tial breakdown of GRP78 provoked the UPR triggering transient
Akt phosphorylation and subsequent NF-κB activation exclusively
via ATF6 signaling; as dominant negative inhibition of IRE1α,
XBP1, or PERK did not attenuate activation of NF-κB. Zhang
et al. (2006) also claimed that under ER stress, CREBH and ATF6
may dimerize and synergistically activate transcription of major
APR genes inducing a systemic inflammatory response.
NF-κB ACTIVATION IN NEURODEGENERATION
In the central nervous system, NF-κB complexes are expressed
by neurons, glial cells, and oligodendrocytes. Constitutive NF-
κB activity is fundamental to physiological processes of brain
development, synaptic signaling that govern learning and mem-
ory, and neuroprotection. Nonetheless, inducible NF-κB activity
is observed in pathological conditions like trauma, ischemia, neu-
rodegenerative diseases, memory dysfunction, and many more.
The existence of diverse NF-κB complexes (Rel/NF-κB homod-
imers and heterodimers), their specificities for certain cell types,
activating stimuli, responsive genes, explains the contradictory
function of NF-κB in cell death and survival (Bhakar et al., 2002;
Pizzi and Spano, 2006). Stimulatory signals for NF-κB activa-
tion in neurons can be stress- or injury-related or on exposure
to cytokines or other signaling molecules including TNFα, glu-
tamate, NGF, ADNF, and sAPP. These are capable of triggering
downstream kinase cascades like calcium/calmodulin-dependent
kinase II, Akt, protein kinase C, which may terminate in high con-
stitutive neuronal NF-κB activity leading to signal transduction
pathways and expression of inflammatory cytokines, chemokines,
immune receptors, and cell surface adhesion molecules (Pahl,
1999; Li and Stark, 2002). NF-κB induces genes supporting cell
survival like those of inhibitors of apoptosis proteins (IAPs), BCL-
2s, TRAF1/TRAF2, and SOD. Glucose deprivation induces injury
and excitotoxicity stress elevates intracellular calcium concen-
trations in embryonic neurons to toxic levels, which on TNFα
administration are decreased by regulating the expression of pro-
teins involved in calcium homeostasis thereby promoting neuronal
survival. TNFα also protects neurons by increasing expression
of anti-apoptotic proteins Bcl-2 and Bcl-xL in hypoxic or nitric
oxide-induced injury (Cheng et al., 1994; Mattson et al., 1997;
Tamatani et al., 1999). Downregulation of NF-κB in the hippocam-
pus is associated Aβ1–42-mediated decline of neurogenesis (Zheng
et al., 2013).
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In glial cells (microglia and astrocytes), inducible NF-kB activ-
ity may indirectly promote neuronal death by producing large
amounts of NO, proinflammatory cytokines interleukin-1b (IL-
1b), interleukin-6 (IL-6) and TNF-α, ROS, and excitotoxins (John
et al., 2003; Kim and de Vellis, 2005; Hsiao et al., 2013). Thus acti-
vation of NF-κB in neurons could promote their survival, whereas
activation of NF-κB in glial cells may induce the production of
neurotoxins depending on the context, i.e., cell type, stimulus,
duration, and threshold levels of effectors (Mattson and Meffert,
2006). Nonaka et al. (1999) demonstrated remarkable prolonged
activation of NF-κB persistent up to a year in glia following brain
trauma in experimental rats suggesting NF-κB’s role in long-term
inflammatory processes.
THERAPEUTIC IMPLICATIONS
Researchers have concentrated their focus on identifying small
molecules acting as chaperones to help stabilize misfolded pro-
teins facilitating protein folding and alleviating ER stress. 4-Phenyl
butyric acid (4-PBA) and taurine-conjugated ursodeoxycholic
acid (TUDCA) are being explored in this regard for various dis-
eases like colitis, atherosclerosis, and type 2 diabetes (Ozcan et al.,
2006; Erbay et al., 2009; Cao et al., 2013; Vang et al., 2014). It is
also known that Lipopolysaccharides (LPS) can induce various ER
stress markers such as GRP78, CHOP in the lung tissues of LPS-
treated mice while an ER stress inhibitor 4-phenylbutyrate (PBA),
can reduce the LPS-induced lung inflammation in mice model
(Kim et al., 2013). A novel strategy of inhibiting IRE1α endonu-
clease activity, without affecting its kinase activity has come to light
identifying small molecules like MK3946 and STF-083010, as ther-
apeutic options for multiple myeloma (MM) therapy. MK3946, an
IRE1α endoribonuclease domain inhibitor, blocked XBP1 splic-
ing causing death of MM cells and/or enhanced sensitivity of
MM cells to other ER stress-inducing drugs bortezomib and
17-AAG, thereby proving to be of efficient lead for MM treat-
ment (Mimura et al., 2012). Dinaciclib (SCH727965), a potent
inhibitor of cyclin-dependent kinase (CDKs) 1/2/5/9, at extremely
low (e.g., nmol/L) concentrations downregulated thapsigargin
and tunicamycin-induced XBP1s and Grp78 expression in human
leukemia and myeloma cells in association with evident cell death.
It also markedly reduced myeloma cell growth in in vivo mod-
els (Nguyen and Grant, 2014). Similarly, STF-083010 exhibited
cytostatic and cytotoxic activity in various MM cell lines and
also effectively reduced tumor grown as xenografts in NSG mice
models. It showed significant ex vivo toxicity to CD138+ cells
(marker for plasma and MM cells) isolated from MM patients
(Papandreou et al., 2011). Another approach in targeting UPR for
therapeutic applications found GSK2656157, an ATP-competitive
inhibitor of PERK enzyme, which inhibited multiple human
tumor xenografts growth in mice (Atkins et al., 2013). In diet-
induced obesity (DIO), C57BL/6J mice, atorvastatin treatment
effectively improved pancreatic β cell function through improved
proliferation, sensitivity to glucose, and attenuated ER stress (Chen
et al., 2014). Gemigliptin, a dipeptidyl peptidase-IV inhibitor
efficiently inhibited ER-stress-mediated apoptosis and inflamma-
tion in cardiomyocytes via Akt/PERK/CHOP and IRE1α/JNK-p38
pathways proposing to have direct beneficial effects to prevent
the progression of cardiovascular diseases (Hwang et al., 2014).
In Sprague-Dawley rats, post traumatic brain surgery adminis-
tration of docosahexaenoic reduced ER stress marker proteins,
ubiquitinated proteins, amyloid precursor protein/p-Tau proteins,
and neurological deficits demanding further research (Begum
et al., 2014). Wang et al. (2014) showed that Propofol, a clini-
cally used anesthetic agent up regulates BiP, XBP1s, and cleaved
ATF6, which may be involved in the adaptive ER stress and atten-
uates ER stress-induced phosphorylation of PERK and eIF2a, and
inhibits the up-regulation of ATF4 and CHOP as well. Synthetic
compound libraries targeting specific components of ER stress
pathways are being evaluated in in vitro and in vivo conditions.
For instance chromenone-based inhibitors of IRE1 RNase activ-
ity and small-molecule PERK inhibitors have been tested in cell
lines (Pytel et al., 2014; Ranatunga et al., 2014). Interleukin-1
receptor-associated kinase-2 (IRAK2) is recently being identified
as amplifier of IRE pathway in addition to its known functions in
innate immunity. Therapeutic targeting of this molecule shall shed
some light in understanding of pathogenesis of ER stress-related
and inflammatory diseases (Benosman et al., 2013).
CONCLUSION
Endoplasmic reticulum is a dynamic organelle orchestrating sev-
eral crucial pathways that decide cellular fate. It senses alterations
in ER homeostasis and triggers UPR pathways with an aim to
initially restore homeostasis by activating genes involved in pro-
tein folding and degrading machinery transcribed by factors like
ATF6, XBP1, and ATF4. If unresolved, it initiates cell death path-
ways. Under such situations, UPR pathways triggers, affects, and
integrates with mitochondrial cellular signaling pathways. Neu-
rodegenerative diseases, inflammatory diseases, cardiovascular
diseases, diabetes mellitus, cancer, and several metabolic diseases
have perturbed ER functions, which contribute to their pathogene-
sis to some extent considering the existence of other complications
like inflammation or oxidative stress. Recent findings have revealed
interconnections between ER stress, inflammation, and oxida-
tive stress pathways under pathological conditions. Thus, further
understanding of the molecular mechanisms in these intercon-
necting pathways occurring in numerous diseases may lead to
discovery of novel therapeutic targets.
However, comprehensive research is demanded to aim UPR in
diseases, wherein side effects, efficacy, and safety are major con-
cerns. Nonetheless, there still exists a dilemma regarding ER stress
being a cause or consequence for a particular diseased condition.
Mitigating ER stress will certainly be of therapeutic significance
keeping in mind that components involved in ER stress-induced
inflammation are targeted specifically with minimal side effects
and only desired cells are acted upon sparing the healthy cells.
Focused research and in-depth investigations in this direction are
needed for a new therapeutic strategy.
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